CDEK by Data4ThePeople

Sign in Sign up

← All organizations

Protein Sciences Corp

For profit

Also known as: MicroGeneSys Inc | MicroGeneSys Inc (nka Protein Sciences Corporation) | Protein Sciences Corporation

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

First marketed drug

Last known activity

Jul 1, 2015

Acquired by Sanofi-Aventis on Aug 1, 2017

Timeline

1980s

Jan 1, 1983
Protein Sciences Corp— Founded

2010s

Jan 16, 2013
inactivated influenza vaccine— NDA Secondary Org
Aug 1, 2017
Sanofi-Aventis— Acquired By

Drugs by trial phase (6 distinct, 18 trials)

Phase 3 (4 own, 0 via acquisition)

Phase 2 (1 own, 0 via acquisition)

panblok

Phase 1 (1 own, 0 via acquisition)

gp160 vaccine

Indications

Studied for

Marketed drugs (1)

inactivated influenza vaccine

Recent trials (20)

NCT02464163Lead sponsorPhase 1/Phase 2Jul 1, 2015
NCT02285998Lead sponsorPhase 3Oct 1, 2014
NCT02290509Lead sponsorPhase 3Oct 1, 2014
NCT01959945Lead sponsorPhase 3Nov 1, 2013
NCT01959945Study chairPhase 3Nov 1, 2013
NCT01825200Lead sponsorPhase 3Mar 1, 2013
NCT01612000Lead sponsorPhase 1/Phase 2May 1, 2012
NCT01147068Reponsible party - principal investigatorPhase 1/Phase 2Jun 1, 2010
NCT01147068Lead sponsorPhase 1/Phase 2Jun 1, 2010
NCT00539981Lead sponsorPhase 3Sep 1, 2007
NCT00539864Lead sponsorPhase 3Sep 1, 2007
NCT00336453Lead sponsorPhase 1/Phase 2Oct 1, 2006
NCT00395174Lead sponsorPhase 3Oct 1, 2006
NCT00328107Lead sponsorPhase 2/Phase 3Nov 1, 2004
NCT00000977CollaboratorPhase 1Nov 2, 1999

Details

Founded: Meriden, CT, US Jan 1, 1983
Last known activity: Jul 1, 2015

Notes

Acquired by Sanofi in 2017